Inventor · disambiguated record
Vanessa Taylor
Also filed as: TAYLOR VANESSA · TAYLOR VANESSA CLAIRE
89 granted patents·23 pending applications·637 citations·filing 2005–2024
99Inventor score
Top patents by PatentIndex Score
112 records- 0198US11479543B2Heterocyclic RIP1 kinase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Oct 25, 2022·5 cites·3 claims
- 0297US11407736B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·4 cites·8 claims
- 0397US10975064B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Apr 13, 2021·14 cites·18 claims
- 0497US7858633B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Dec 28, 2010·66 cites·5 claims
- 0597US7834024B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted Nov 16, 2010·59 cites·6 claims
- 0696US11584758B2RIP1K inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·5 cites·37 claims
- 0796US11332451B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted May 17, 2022·3 cites·13 claims
- 0896US10815206B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·16 cites·17 claims
- 0996US10590121B2Kinase inhibitors and methods for making and usingRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Mar 17, 2020·10 cites·37 claims
- 1096US8415365B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Apr 9, 2013·31 cites·20 claims
- 1196US7947698B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·55 cites·54 claims
- 1296US7915273B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2010·Granted Mar 29, 2011·33 cites·2 claims
- 1396US7754714B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·39 cites·24 claims
- 1495US9982000B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted May 29, 2018·16 cites·14 claims
- 1595US8735400B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted May 27, 2014·21 cites·24 claims
- 1695US8399472B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2008·Granted Mar 19, 2013·26 cites·4 claims
- 1795US8324200B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Dec 4, 2012·23 cites·46 claims
- 1894US11370787B2Pyrazole compounds, formulations thereof, and a method for using the compounds and/or formulationsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·4 cites·23 claims
- 1994US7868013B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Jan 11, 2011·25 cites·12 claims
- 2093US11377428B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·2 cites·13 claims
- 2193US11370765B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 2293US11370764B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Jun 28, 2022·2 cites·13 claims
- 2393US8299087B2Compositions and methods for inhibition of the JAK pathwayLI HUI·Filed 2010·Granted Oct 30, 2012·11 cites·4 claims
- 2492US9067925B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2012·Granted Jun 30, 2015·11 cites·10 claims
- 2591US11198689B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2019·Granted Dec 14, 2021·2 cites·18 claims
- 2690US10774076B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Sep 15, 2020·3 cites·21 claims
- 2790US10208074B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·5 cites·11 claims
- 2890US8304422B2Compositions and methods for inhibition of the JAK pathwayATUEGBU ANDY·Filed 2010·Granted Nov 6, 2012·26 cites·22 claims
- 2989US10208075B2Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2018·Granted Feb 19, 2019·4 cites·17 claims
- 3089US8815848B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 26, 2014·8 cites·5 claims
- 3189US8410093B2Cycloalkyl substituted pyrimidinediamine compounds and their usesLI HUI·Filed 2010·Granted Apr 2, 2013·9 cites·20 claims
- 3289US8343954B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2011·Granted Jan 1, 2013·8 cites·7 claims
- 3389US2025034100A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3489US2025326778A1Pyrazole compounds and method for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3588US11919890B2RIP1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Mar 5, 2024·1 cites·18 claims
- 3688US11530194B2Amide compounds and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Dec 20, 2022·1 cites·24 claims
- 3788US11492349B2IRAK inhibitors and method for making and usingRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Nov 8, 2022·1 cites·21 claims
- 3888US9732073B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·4 cites·17 claims
- 3988US9611260B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Apr 4, 2017·4 cites·14 claims
- 4087US10421752B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Sep 24, 2019·3 cites·14 claims
- 4187US9725419B2Cycloalkyl substituted pyrimidinediamine compounds and their usesRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Aug 8, 2017·7 cites·3 claims
- 4287US9566283B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·3 cites·12 claims
- 4387US9248132B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·1 claims
- 4487US9084795B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·4 cites·19 claims
- 4587US2024368119A1Rip1 inhibitory compounds and methods for making and using the sameRIGEL PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4686US11299486B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2020·Granted Apr 12, 2022·1 cites·11 claims
- 4786US10065946B2Benzazole compounds and methods for making and using the compoundsRIGEL PHARMACEUTICALS INC·Filed 2016·Granted Sep 4, 2018·4 cites·24 claims
- 4886US8268851B2Compositions and methods for inhibition of the JAK pathwayBHAMIDIPATI SOMASEKHAR·Filed 2009·Granted Sep 18, 2012·8 cites·14 claims
- 4985US9481654B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·5 cites·19 claims
- 5085US9248190B2Compositions and methods for inhibition of the JAK pathwayRIGEL PHARMACEUTICALS INC·Filed 2014·Granted Feb 2, 2016·4 cites·7 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →